Search

Your search keyword '"Weizman, Adam V."' showing total 186 results

Search Constraints

Start Over You searched for: Author "Weizman, Adam V." Remove constraint Author: "Weizman, Adam V."
186 results on '"Weizman, Adam V."'

Search Results

1. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters

8. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters

9. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis

10. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

12. The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape

15. 2023 Impact of Inflammatory Bowel Disease in Canada

25. Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials

31. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis

32. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters

34. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

37. Identification of Target Golimumab Levels in Maintenance Therapy of Crohn’s Disease and Ulcerative Colitis Associated With Mucosal Healing

38. Development of a Global Rating Scale for Inflammatory Bowel Disease

39. Sa1863 – Patient Empowerment Through an Educational Intervention Improves Patient Satisfaction and Trust in Physician Among Hospitalized Patients with Ulcerative Colitis

46. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada

48. Appropriateness of Biologics in the Management of Crohn’s Disease Using RAND/UCLA Appropriateness Methodology

49. Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease

50. List of Contributors

Catalog

Books, media, physical & digital resources